FY2025 · ended Dec 31, 2025 · Revenue $28,000 · Filed Mar 23, 2026
Talphera, Inc. (TLPH) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $28,000 and a net loss of $14.3 million.
Revenue (TTM)
$1,000
-96.3% vs year-ago TTM
Net income (TTM)
$-15.08M
-33.4% vs year-ago TTM
Operating cash flow (TTM)
$-12.27M
-5.7% vs year-ago TTM
Free cash flow
$-12.68M
+27.9% vs prior year
EPS
$-1.29
-122.6% vs prior year
Dividend per share
None
Shares outstanding
50.05M
+192.7% vs prior year
Net cash
$9.38M
FY 2023
Operating margin
-1474700.0%
FY 2026
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TLPH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Mateo, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1427925
- Former names
- ACELRX PHARMACEUTICALS INC (until Dec 14, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $28,000 | $0 | $651,000 | $0 | $2.8M |
| Operating income | -$13.5M | -$15.3M | -$16.9M | -$25.3M | -$36.0M |
| Net income | -$14.3M | -$13.0M | -$18.4M | $47.8M | -$35.1M |
| Diluted EPS | — | — | -$1.29 | $5.72 | — |
| Operating cash flow | -$11.4M | -$12.7M | -$17.5M | -$28.3M | -$30.0M |
| Free cash flow | — | -$12.7M | -$17.6M | -$28.7M | -$31.8M |
| Total assets | $29.7M | $18.2M | $20.4M | $47.5M | $77.9M |
| Total liabilities | $12.7M | $10.2M | $6.3M | $25.7M | $113.8M |
| Stockholders' equity | $17.0M | $8.0M | $14.1M | $21.8M | -$35.9M |
| Cash and investments | $20.4M | $8.9M | $9.4M | $15.8M | $46.6M |
| Total debt | — | — | $0 | $10.4M | $18.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 23, 2026 | Jun 22, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 10-K | Annual report | Mar 23, 2026 | Dec 31, 2025 |
All 962 Talphera, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.